162 related articles for article (PubMed ID: 21161428)
1. Coronary angiography in noncompaction with and without neuromuscular disorders.
Stöllberger C; Finsterer J; Blazek G; Hanafin A; Winkler-Dworak M
Ir J Med Sci; 2011 Sep; 180(3):667-72. PubMed ID: 21161428
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of Neuromuscular Co-morbidity, Left Bundle Branch Block, and Atrial Fibrillation to Predict the Long-Term Prognosis of Left Ventricular Hypertrabeculation/Noncompaction.
Stöllberger C; Hasun M; Winkler-Dworak M; Finsterer J
Am J Cardiol; 2020 Aug; 128():168-173. PubMed ID: 32650915
[TBL] [Abstract][Full Text] [Related]
3. Neuromuscular and cardiac comorbidity determines survival in 140 patients with left ventricular hypertrabeculation/noncompaction.
Stöllberger C; Blazek G; Wegner C; Winkler-Dworak M; Finsterer J
Int J Cardiol; 2011 Jul; 150(1):71-4. PubMed ID: 20226551
[TBL] [Abstract][Full Text] [Related]
4. Coronary Angiography in Patients With Left Ventricular Hypertrabeculation/Noncompaction.
de Cillia N; Finsterer J; Campean R; Noorian A; Winkler-Dworak M; Stöllberger C
Tex Heart Inst J; 2024 May; 51(1):. PubMed ID: 38805371
[TBL] [Abstract][Full Text] [Related]
5. Heart failure, atrial fibrillation and neuromuscular disorders influence mortality in left ventricular hypertrabeculation/noncompaction.
Stöllberger C; Blazek G; Wegner C; Finsterer J
Cardiology; 2011; 119(3):176-82. PubMed ID: 21968288
[TBL] [Abstract][Full Text] [Related]
6. Neuromuscular disorders in left ventricular hypertrabeculation/noncompaction.
Finsterer J; Stöllberger C; Fazio G
Curr Pharm Des; 2010; 16(26):2895-904. PubMed ID: 20632953
[TBL] [Abstract][Full Text] [Related]
7. Cardiologic and neurologic findings in left ventricular hypertrabeculation/noncompaction relating to echocardiographic indication.
Stöllberger C; Winkler-Dworak M; Blazek G; Finsterer J
Int J Cardiol; 2007 Jun; 119(1):28-32. PubMed ID: 17023079
[TBL] [Abstract][Full Text] [Related]
8. Cardiac and neuromuscular implications of left bundle branch block in left ventricular hypertrabeculation/noncompaction.
Stöllberger C; Blazek G; Winkler-Dworak M; Finsterer J
Can J Cardiol; 2009 Mar; 25(3):e82-5. PubMed ID: 19279992
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of left ventricular hypertrabeculation/noncompaction is dependent on cardiac and neuromuscular comorbidity.
Stöllberger C; Winkler-Dworak M; Blazek G; Finsterer J
Int J Cardiol; 2007 Oct; 121(2):189-93. PubMed ID: 17188376
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of left ventricular hypertrabeculation/noncompaction among children with sickle cell disease.
Morrison ML; McMahon C; Tully R; Enright N; Pignatelli R; Towbin JA; McMahon CJ
Congenit Heart Dis; 2018 May; 13(3):440-443. PubMed ID: 29468808
[TBL] [Abstract][Full Text] [Related]
11. Age-dependency of cardiac and neuromuscular findings in adults with left ventricular hypertrabeculation/noncompaction.
Stöllberger C; Blazek G; Gessner M; Bichler K; Wegner C; Finsterer J
Am J Cardiol; 2015 May; 115(9):1287-92. PubMed ID: 25791238
[TBL] [Abstract][Full Text] [Related]
12. Neuromuscular comorbidity, heart failure, and atrial fibrillation as prognostic factors in left ventricular hypertrabeculation/noncompaction.
Stöllberger C; Blazek G; Gessner M; Bichler K; Wegner C; Finsterer J
Herz; 2015 Sep; 40(6):906-11. PubMed ID: 25939437
[TBL] [Abstract][Full Text] [Related]
13. In- and outpatients with noncompaction: differences in cardiac and neuromuscular co-morbidity.
Stöllberger C; Blazek G; Winkler-Dworak M; Finsterer J
Int J Cardiol; 2010 Apr; 140(1):108-11. PubMed ID: 19095319
[TBL] [Abstract][Full Text] [Related]
14. Cardiologic and neuromuscular co-morbidity influences mortality of patients with left ventricular hypertrabeculation/noncompaction: comparison with the Austrian general population.
Stöllberger C; Winkler-Dworak M; Blazek G; Finsterer J
Acta Cardiol; 2007 Feb; 62(1):1-5. PubMed ID: 17375885
[TBL] [Abstract][Full Text] [Related]
15. Frequency of stroke and embolism in left ventricular hypertrabeculation/noncompaction.
Stöllberger C; Blazek G; Dobias C; Hanafin A; Wegner C; Finsterer J
Am J Cardiol; 2011 Oct; 108(7):1021-3. PubMed ID: 21784395
[TBL] [Abstract][Full Text] [Related]
16. [Sex differences in left ventricular noncompaction in patients with and without neuromuscular disorders].
Stöllberger C; Blazek G; Winkler-Dworak M; Finsterer J
Rev Esp Cardiol; 2008 Feb; 61(2):130-6. PubMed ID: 18364181
[TBL] [Abstract][Full Text] [Related]
17. Understanding left ventricular hypertrabeculation/noncompaction: pathomorphologic findings and prognostic impact of neuromuscular comorbidities.
Stöllberger C; Finsterer J
Expert Rev Cardiovasc Ther; 2019 Feb; 17(2):95-109. PubMed ID: 30570401
[TBL] [Abstract][Full Text] [Related]
18. Atrial fibrillation in left ventricular noncompaction with and without neuromuscular disorders is associated with a poor prognosis.
Stöllberger C; Blazek G; Winkler-Dworak M; Finsterer J
Int J Cardiol; 2009 Mar; 133(1):41-5. PubMed ID: 18255171
[TBL] [Abstract][Full Text] [Related]
19. Neurological comorbidity affects prognosis in left ventricular hypertrabeculation/noncompaction.
Stöllberger C; Blazek G; Wegner C; Finsterer J
Heart Lung; 2012; 41(6):594-8. PubMed ID: 22515930
[TBL] [Abstract][Full Text] [Related]
20. CHADS2- and CHA2DS2VASc scores and embolic risk in left ventricular hypertrabeculation/noncompaction.
Stöllberger C; Wegner C; Finsterer J
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):709-12. PubMed ID: 22142779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
